(Q43521216)

English

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact (English)

1 reference

Europe PubMed Central

24 November 2017

Emanuela Scarpi

3

1 reference

Europe PubMed Central

24 November 2017

7

1 reference

Europe PubMed Central

24 November 2017

Alberto Farolfi

object named as

Alberto Farolfi

2

0 references

object named as

Toni Ibrahim

1

0 references

Laura Mercatali

object named as

Laura Mercatali

4

0 references

author name string

Laura Medri

5

1 reference

Europe PubMed Central

24 November 2017

Marianna Ricci

6

1 reference

Europe PubMed Central

24 November 2017

Luigi Serra

8

1 reference

Europe PubMed Central

24 November 2017

Dino Amadori

9

1 reference

Europe PubMed Central

24 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 December 2012

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

84

1 reference

Europe PubMed Central

24 November 2017

3

1 reference

Europe PubMed Central

24 November 2017

150-157

1 reference

Europe PubMed Central

24 November 2017

Predictive markers in breast cancer--the present

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Should liver metastases of breast cancer be biopsied to improve treatment choice?

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Ki67 in breast cancer: prognostic and predictive potential

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Adjuvant trastuzumab in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Mammary development meets cancer genomics.

1 reference

https://api.crossref.org/works/10.1159%2F000345795

21 January 2018

Identifiers

10.1159/000345795

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43521216&oldid=1990501490"